ATE453634T1 - Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen - Google Patents

Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen

Info

Publication number
ATE453634T1
ATE453634T1 AT06813938T AT06813938T ATE453634T1 AT E453634 T1 ATE453634 T1 AT E453634T1 AT 06813938 T AT06813938 T AT 06813938T AT 06813938 T AT06813938 T AT 06813938T AT E453634 T1 ATE453634 T1 AT E453634T1
Authority
AT
Austria
Prior art keywords
thiophenes
preparing benzimidazole
regioselective process
preparing
benzimidazole
Prior art date
Application number
AT06813938T
Other languages
English (en)
Inventor
Keith Hornberger
Mui Cheung
Mark Pobanz
Kyle Emmitte
Kevin Kuntz
Jennifer Badiang
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE453634T1 publication Critical patent/ATE453634T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D333/40Thiophene-2-carboxylic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT06813938T 2005-09-06 2006-08-28 Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen ATE453634T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71430105P 2005-09-06 2005-09-06
PCT/US2006/033793 WO2007030366A1 (en) 2005-09-06 2006-08-28 Regioselective process for preparing benzimidazole thiophenes

Publications (1)

Publication Number Publication Date
ATE453634T1 true ATE453634T1 (de) 2010-01-15

Family

ID=37605702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06813938T ATE453634T1 (de) 2005-09-06 2006-08-28 Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen

Country Status (18)

Country Link
US (1) US20080249301A1 (de)
EP (1) EP1924572B1 (de)
JP (1) JP2009507022A (de)
KR (1) KR20080045266A (de)
CN (1) CN101304986A (de)
AT (1) ATE453634T1 (de)
AU (1) AU2006287771A1 (de)
BR (1) BRPI0615705A2 (de)
CA (1) CA2621073A1 (de)
DE (1) DE602006011482D1 (de)
EA (1) EA200800549A1 (de)
ES (1) ES2338590T3 (de)
IL (1) IL189769A0 (de)
MA (1) MA29781B1 (de)
MX (1) MX2008003172A (de)
NO (1) NO20081101L (de)
WO (1) WO2007030366A1 (de)
ZA (1) ZA200801950B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070518A1 (es) * 2005-09-06 2007-06-12 Smithkline Beecham Corp Compuestos de tiofeno bencimidazol como agentes inhibidores de plk
CN101331126A (zh) * 2005-09-06 2008-12-24 史密丝克莱恩比彻姆公司 作为plk调节剂的苯并咪唑噻吩化合物
WO2007087283A2 (en) * 2006-01-23 2007-08-02 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
EP2007757B1 (de) 2006-04-13 2012-10-03 Vertex Pharmceuticals Incorporated Als protein-kinase-inhibitoren nutzbare thiophen-carboxamide
US8853244B2 (en) 2006-05-23 2014-10-07 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
US7851495B2 (en) 2006-05-23 2010-12-14 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
US7615643B2 (en) 2006-06-02 2009-11-10 Smithkline Beecham Corporation Benzimidazole thiophene compounds
EP2170871A2 (de) * 2007-06-26 2010-04-07 GlaxoSmithKline LLC Verfahren zur herstellung von benzimidazolthiophenen
EP2100894A1 (de) 2008-03-12 2009-09-16 4Sc Ag Pyridopyrimidinone verwendbar als Plk1 (polo-like kinase) Hemmen
WO2011130194A2 (en) * 2010-04-12 2011-10-20 Supernus Pharmaceuticals Inc. Methods for producing viloxazine salts and novel polymorphs thereof
US20130315895A1 (en) 2010-07-01 2013-11-28 Takeda Pharmaceutical Company Limited COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
EP2565186A1 (de) 2011-09-02 2013-03-06 Hybrigenics S.A. Spezifische und reversible Inhibitoren von ubiquitinspezifischer Protease 7
BR112014025201A2 (pt) 2012-04-10 2017-07-11 Sumitomo Dainippon Pharma Co Ltd derivado de indazol 1-substituído
CN107652289B (zh) 2012-06-13 2020-07-21 因塞特控股公司 作为fgfr抑制剂的取代的三环化合物
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
JP6449244B2 (ja) 2013-04-19 2019-01-09 インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation Fgfr抑制剤としての二環式複素環
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
WO2016134320A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
EP3728228A1 (de) 2017-12-22 2020-10-28 Ravenna Pharmaceuticals, Inc. Aminopyridinderivate als phosphatidylinositol-phosphatkinase-inhibitoren
SG11202010882XA (en) 2018-05-04 2020-11-27 Incyte Corp Salts of an fgfr inhibitor
DK3788047T3 (da) 2018-05-04 2024-09-16 Incyte Corp Faste former af en FGFR-inhibitor og fremgangsmåder til fremstilling deraf
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
CN109988098A (zh) * 2019-05-23 2019-07-09 常州工程职业技术学院 一种(r)-n-叔丁氧羰基-3-羟甲基哌啶的合成方法
TW202112767A (zh) 2019-06-17 2021-04-01 美商佩特拉製藥公司 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
MX2022004513A (es) 2019-10-14 2022-07-19 Incyte Corp Heterociclos biciclicos como inhibidores de los receptores del factor de crecimiento de fibroblastos (fgfr).
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
JP2023505258A (ja) 2019-12-04 2023-02-08 インサイト・コーポレイション Fgfr阻害剤としての三環式複素環
BR112022010664A2 (pt) 2019-12-04 2022-08-16 Incyte Corp Derivados de um inibidor de fgfr
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
EP4323405A1 (de) 2021-04-12 2024-02-21 Incyte Corporation Kombinationstherapie mit einem fgfr-inhibitor und einem auf nectin-4 abzielenden mittel
CA3220274A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990146A (en) * 1997-08-20 1999-11-23 Warner-Lambert Company Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
US6162804A (en) * 1997-09-26 2000-12-19 Merck & Co., Inc. Tyrosine kinase inhibitors
GB0005642D0 (en) * 2000-03-10 2000-05-03 Astrazeneca Uk Ltd Chemical compounds
CA2465328C (en) * 2001-11-01 2011-06-14 Michael Francis Gross Piperidines
US20060074119A1 (en) * 2002-08-08 2006-04-06 Andrews Clarence W Iii Thiophene compounds
US7491737B2 (en) * 2002-10-30 2009-02-17 Merck & Co., Inc. Heterarylpiperidine modulators of chemokine receptor activity
JP2007509070A (ja) * 2003-10-16 2007-04-12 スミスクライン ビーチャム コーポレーション チオフェン化合物

Also Published As

Publication number Publication date
US20080249301A1 (en) 2008-10-09
EP1924572A1 (de) 2008-05-28
EA200800549A1 (ru) 2008-08-29
EP1924572B1 (de) 2009-12-30
DE602006011482D1 (de) 2010-02-11
JP2009507022A (ja) 2009-02-19
IL189769A0 (en) 2008-08-07
WO2007030366A1 (en) 2007-03-15
MA29781B1 (fr) 2008-09-01
BRPI0615705A2 (pt) 2016-08-23
NO20081101L (no) 2008-04-04
CN101304986A (zh) 2008-11-12
KR20080045266A (ko) 2008-05-22
ES2338590T3 (es) 2010-05-10
AU2006287771A1 (en) 2007-03-15
CA2621073A1 (en) 2007-03-15
ZA200801950B (en) 2009-09-30
MX2008003172A (es) 2008-03-18

Similar Documents

Publication Publication Date Title
ATE453634T1 (de) Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen
UY33981A (es) ?método para preparar compuestos macrocíclicos inhibidores de serina proteasas de hepatitis c?.
DE602005015174D1 (de) Verfahren zur herstellung von montelukast-natrium
DE502006001614D1 (de) Verfahren zur herstellung von 1-alkyl-3-phenyluracilen
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
CY1110010T1 (el) Πυριδιναμινοσουλφονυλ υποκατεστημενα βενζαμιδια ως αναστολεις κυτοχρωματος ρ450 3α4 (cyp3a4)
HRP20090213A2 (en) Process and intermediates for preparing integrase inhibitors
DE602006014670D1 (de) Verfahren zur doppelbindungs-hydroisomerisierung von butenen
ATE522518T1 (de) Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
ATE485279T1 (de) Verbessertes verfahren zur herstellung der salze von 4-(benzimidazolylmethylamin)-benzamiden
DE502005004141D1 (de) Verfahren zur kompensation von thermischen verlagerungen
DE602007009096D1 (de) Verfahren zur herstellung von benzopyran-2-olderivaten
CY1118173T1 (el) 5-[(3,3,3-τριφθορο-2-υδροξυ-1-αρυλπροπυλ)αμινο]-1h-κινολιν-2-ονες, μια διεργασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδων παραγοντων
EA200900945A1 (ru) Новый способ синтеза агомелатина
CY1112520T1 (el) Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες
TNSN06260A1 (en) Process for the preparation of tryptase inhibitors
DE502005007702D1 (de) Verfahren zur herstellung von terrylen-3,4:11,12-t
EA200801549A1 (ru) Новые производные фенантридина в качестве антагонистов брадикинина
ATE519722T1 (de) Verfahren zur palladiumkatalysierten kopplung von terminalalkynen mit aryltosylaten
DE502007003531D1 (de) Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten
DE502007000339D1 (de) Verfahren zur Herstellung von Urethangruppen aufweisenden Organosiliciumverbindungen
DE602006017671D1 (de) Verfahren zur herstellung von tricarbonsäuretris(alkylsubstituiertes cyclohexylamid)
DE602006017011D1 (de) Verfahren zur Herstellung von Mannich Kondensationsprodukte zur Verwendung als Chelatbildner
DE112009000076A5 (de) Verfahren zur Herstellung von Urethanen
DE602006018331D1 (de) 4-(1h-indazol-5-ylamino)chinazolinverbindungen als inhibitoren der erbb-rezeptortyrosinkinase zur behandlung von krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties